AAAAAA

   
Results: 1-25 | 26-35
Results: 1-25/35
VACCINATION AGAINST TICK-BORNE ENCEPHALIT IS
Authors: MAASS G
Citation: G. Maass, VACCINATION AGAINST TICK-BORNE ENCEPHALIT IS, Deutsche Medizinische Wochenschrift, 123(13), 1998, pp. 405-406
RECOMBINANT ADENOASSOCIATED VIRUS FOR THE GENERATION OF AUTOLOGOUS, GENE-MODIFIED TUMOR VACCINES - EVIDENCE FOR A HIGH TRANSDUCTION EFFICIENCY INTO PRIMARY EPITHELIAL CANCER-CELLS
Authors: MAASS G BOGEDAIN C SCHEER U MICHL D HORER M BRAUNFALCO M VOLKENANDT M SCHADENDORF D WENDTNER CM WINNACKER EL KOTIN RM HALLEK M
Citation: G. Maass et al., RECOMBINANT ADENOASSOCIATED VIRUS FOR THE GENERATION OF AUTOLOGOUS, GENE-MODIFIED TUMOR VACCINES - EVIDENCE FOR A HIGH TRANSDUCTION EFFICIENCY INTO PRIMARY EPITHELIAL CANCER-CELLS, Human gene therapy, 9(7), 1998, pp. 1049-1059
CLONING OF PROKARYOTIC GENOMES IN YEAST ARTIFICIAL CHROMOSOMES - APPLICATION TO THE POPULATION-GENETICS OF PSEUDOMONAS-AERUGINOSA
Authors: HEUER T BURGER C MAASS G TUMMLER B
Citation: T. Heuer et al., CLONING OF PROKARYOTIC GENOMES IN YEAST ARTIFICIAL CHROMOSOMES - APPLICATION TO THE POPULATION-GENETICS OF PSEUDOMONAS-AERUGINOSA, Electrophoresis, 19(4), 1998, pp. 486-494
GENE-TRANSFER OF COSTIMULATORY MOLECULES B7-1 AND B7-2 INTO HUMAN MULTIPLE-MYELOMA CELLS BY RECOMBINANT ADENOASSOCIATED VIRUS ENHANCES THE CYTOLYTIC T-CELL RESPONSE
Authors: WENDTNER CM NOLTE A MANGOLD E BUHMANN R MAASS G CHIORINI JA WINNACKER EL EMMERICH B KOTIN RM HALLEK M
Citation: Cm. Wendtner et al., GENE-TRANSFER OF COSTIMULATORY MOLECULES B7-1 AND B7-2 INTO HUMAN MULTIPLE-MYELOMA CELLS BY RECOMBINANT ADENOASSOCIATED VIRUS ENHANCES THE CYTOLYTIC T-CELL RESPONSE, Gene therapy, 4(7), 1997, pp. 726-735
PHASE-I STUDY TO THE IMMUNOTHERAPY OF METASTATIC MALIGNANT-MELANOMA BY A CANCER VACCINE CONSISTING OF AUTOLOGOUS CANCER-CELLS TRANSFECTED WITH THE HUMAN IL-2 GENE
Authors: STINGL G BROCKER EB MERTELSMANN R WOLFF K SCHREIBER S KAMPGEN E SCHNEEBERGER A TRCKA J BRENNSCHEIDT U VEELKEN H BIRNSTIEL ML ZATLOUKAL K MAASS G WAGNER E BUSCHLE M KEMPE ER WEBER HA VOIGT T
Citation: G. Stingl et al., PHASE-I STUDY TO THE IMMUNOTHERAPY OF METASTATIC MALIGNANT-MELANOMA BY A CANCER VACCINE CONSISTING OF AUTOLOGOUS CANCER-CELLS TRANSFECTED WITH THE HUMAN IL-2 GENE, Journal of molecular medicine, 75(4), 1997, pp. 297-299
DEVELOPMENT OF AUTOLOGOUS CANCER VACCINES USING HIGH-TITER RECOMBINANT ADENOASSOCIATED VIRUS
Authors: HORER M MAASS G BOGEDAIN C KOTIN R BURGER A WINNACKER EL HALLEK M
Citation: M. Horer et al., DEVELOPMENT OF AUTOLOGOUS CANCER VACCINES USING HIGH-TITER RECOMBINANT ADENOASSOCIATED VIRUS, Cancer gene therapy, 4(6), 1997, pp. 148-148
GENERATION OF EFFECTIVE CANCER VACCINES GENETICALLY-ENGINEERED TO SECRETE CYTOKINES USING ADENOVIRUS-ENHANCED TRANSFERRINFECTION (AVET)
Authors: SCHMIDT W MAASS G BUSCHLE M SCHWEIGHOFFER T BERGER M HERBST E SCHILCHER F BIRNSTIEL ML
Citation: W. Schmidt et al., GENERATION OF EFFECTIVE CANCER VACCINES GENETICALLY-ENGINEERED TO SECRETE CYTOKINES USING ADENOVIRUS-ENHANCED TRANSFERRINFECTION (AVET), Gene, 190(1), 1997, pp. 211-216
THE USE OF RECOMBINANT ADENOASSOCIATED VIRAL VECTORS FOR THE TRANSDUCTION OF EPITHELIAL TUMOR-CELLS
Authors: HOERER M BOGEDAIN C SCHEER U HEBERGER C STEYRER S BURGER A MAASS G
Citation: M. Hoerer et al., THE USE OF RECOMBINANT ADENOASSOCIATED VIRAL VECTORS FOR THE TRANSDUCTION OF EPITHELIAL TUMOR-CELLS, International journal of immunopharmacology, 19(9-10), 1997, pp. 473-479
TICK-BORNE ENCEPHALITIS
Authors: MAASS G
Citation: G. Maass, TICK-BORNE ENCEPHALITIS, Deutsche Medizinische Wochenschrift, 121(24), 1996, pp. 812-812
PHASE-I STUDY TO THE IMMUNOTHERAPY OF METASTATIC MALIGNANT-MELANOMA BY A CANCER VACCINE CONSISTING OF AUTOLOGOUS CANCER-CELLS TRANSFECTED WITH THE HUMAN IL-2 GENE
Authors: STINGL G BROCKER EB MERTELSMANN R WOLFF K SCHREIBER S KAMPGEN E SCHNEEBERGER A DUMMER W BRENNSCHEID U VEELKEN H BIRNSTIEL ML ZATLOUKAL K SCHMIDT W MAASS G WAGNER E BUSCHLE M GIESE M KEMPE ER WEBER HA VOIGT T
Citation: G. Stingl et al., PHASE-I STUDY TO THE IMMUNOTHERAPY OF METASTATIC MALIGNANT-MELANOMA BY A CANCER VACCINE CONSISTING OF AUTOLOGOUS CANCER-CELLS TRANSFECTED WITH THE HUMAN IL-2 GENE, Human gene therapy, 7(4), 1996, pp. 551-563
ASP-59 IS NOT IMPORTANT FOR THE CATALYTIC ACTIVITY OF THE RESTRICTION-ENDONUCLEASE ECORI
Authors: GRABOWSKI G MAASS G ALVES J
Citation: G. Grabowski et al., ASP-59 IS NOT IMPORTANT FOR THE CATALYTIC ACTIVITY OF THE RESTRICTION-ENDONUCLEASE ECORI, FEBS letters, 381(1-2), 1996, pp. 106-110
HIGHLY EFFICIENT EX-VIVO GENE-TRANSFER INTO PRIMARY HUMAN TUMOR-CELLSUSING IMPROVED RECOMBINANT ADENOASSOCIATED VIRUS (RAAV) VECTORS
Authors: MAASS G BOGEDAIN C WENDTNER CM SCHEER U VOLKENANDT M MICHL D BARUNFALCO M EMMERICH B KOTIN R WINNACKER EL HALLEK M
Citation: G. Maass et al., HIGHLY EFFICIENT EX-VIVO GENE-TRANSFER INTO PRIMARY HUMAN TUMOR-CELLSUSING IMPROVED RECOMBINANT ADENOASSOCIATED VIRUS (RAAV) VECTORS, Blood, 88(10), 1996, pp. 526-526
INTERLEUKIN-2 TRANSFECTED MELANOMA-CELLS FOR TUMOR VACCINATION - FROMANIMAL-MODELS TO CLINICAL-TRIALS
Authors: MAASS G SCHMIDT W SCHWEIGHOFFER T BERGER M SCHNEEBERGER A ZATLOUKAL K COTTEN M WAGNER E BIRNSTIEL ML
Citation: G. Maass et al., INTERLEUKIN-2 TRANSFECTED MELANOMA-CELLS FOR TUMOR VACCINATION - FROMANIMAL-MODELS TO CLINICAL-TRIALS, European journal of cancer, 31A, 1995, pp. 24-24
SITE-DIRECTED MUTAGENESIS IN THE CATALYTIC CENTER OF THE RESTRICTION-ENDONUCLEASE ECORI
Authors: GRABOWSKI G JELTSCH A WOLFES H MAASS G ALVES J
Citation: G. Grabowski et al., SITE-DIRECTED MUTAGENESIS IN THE CATALYTIC CENTER OF THE RESTRICTION-ENDONUCLEASE ECORI, Gene, 157(1-2), 1995, pp. 113-118
POLIO VACCINATIONS TODAY - CRITICAL REMAR KS
Authors: ALLWINN R MAASS G
Citation: R. Allwinn et G. Maass, POLIO VACCINATIONS TODAY - CRITICAL REMAR KS, Immunitat und Infektion, 23(6), 1995, pp. 3-4
TUMOR VACCINES - EFFECTS AND FATE OF IL-2 TRANSFECTED MURINE MELANOMA-CELLS IN-VIVO
Authors: MAASS G SCHWEIGHOFFER T BERGER M SCHMIDT W HERBST E ZATLOUKAL K BUSCHLE M
Citation: G. Maass et al., TUMOR VACCINES - EFFECTS AND FATE OF IL-2 TRANSFECTED MURINE MELANOMA-CELLS IN-VIVO, International journal of immunopharmacology, 17(2), 1995, pp. 65
PRIMING OF TUMOR-SPECIFIC T-CELLS IN THE DRAINING LYMPH-NODES AFTER IMMUNIZATION WITH INTERLEUKIN 2-SECRETING TUMOR-CELLS - 3 CONSECUTIVE STAGES MAY BE REQUIRED FOR SUCCESSFUL TUMOR VACCINATION
Authors: MAASS G SCHMIDT W BERGER M SCHILCHER F KOSZIK F SCHNEEBERGER A STINGL G BIRNSTIEL ML SCHWEIGHOFFER T
Citation: G. Maass et al., PRIMING OF TUMOR-SPECIFIC T-CELLS IN THE DRAINING LYMPH-NODES AFTER IMMUNIZATION WITH INTERLEUKIN 2-SECRETING TUMOR-CELLS - 3 CONSECUTIVE STAGES MAY BE REQUIRED FOR SUCCESSFUL TUMOR VACCINATION, Proceedings of the National Academy of Sciences of the United Statesof America, 92(12), 1995, pp. 5540-5544
CANCER VACCINES - THE INTERLEUKIN-2 DOSAGE EFFECT
Authors: SCHMIDT W SCHWEIGHOFFER T HERBST E MAASS G BERGER M SCHILCHER F SCHAFFNER G BIRNSTIEL ML
Citation: W. Schmidt et al., CANCER VACCINES - THE INTERLEUKIN-2 DOSAGE EFFECT, Proceedings of the National Academy of Sciences of the United Statesof America, 92(10), 1995, pp. 4711-4714
ELICITATION OF A SYSTEMIC AND PROTECTIVE ANTIMELANOMA IMMUNE-RESPONSEBY AN IL-2-BASED VACCINE - ASSESSMENT OF CRITICAL CELLULAR AND MOLECULAR-PARAMETERS
Authors: ZATLOUKAL K SCHNEEBERGER A BERGER M SCHMIDT W KOSZIK F KUTIL R COTTEN M WAGNER E BUSCHLE M MAASS G PAYER E STINGL G BIRNSTIEL ML
Citation: K. Zatloukal et al., ELICITATION OF A SYSTEMIC AND PROTECTIVE ANTIMELANOMA IMMUNE-RESPONSEBY AN IL-2-BASED VACCINE - ASSESSMENT OF CRITICAL CELLULAR AND MOLECULAR-PARAMETERS, The Journal of immunology, 154(7), 1995, pp. 3406-3419
A DODECAPEPTIDE COMPRISING THE EXTENDED CHAIN-ALPHA-4 REGION OF THE RESTRICTION-ENDONUCLEASE ECORI SPECIFICALLY BINDS TO THE ECORI RECOGNITION SITE
Authors: JELTSCH A ALVES J URBANKE C MAASS G ECKSTEIN H ZHANG LS BAYER E PINGOUD A
Citation: A. Jeltsch et al., A DODECAPEPTIDE COMPRISING THE EXTENDED CHAIN-ALPHA-4 REGION OF THE RESTRICTION-ENDONUCLEASE ECORI SPECIFICALLY BINDS TO THE ECORI RECOGNITION SITE, The Journal of biological chemistry, 270(10), 1995, pp. 5122-5129
VACCINATIONS FOR REFUGEES
Authors: MAASS G
Citation: G. Maass, VACCINATIONS FOR REFUGEES, Der Internist, 36(5), 1995, pp. 521-521
HUMAN LYMPHOID TUMOR-CELLS TRANSDUCED WITH RECOMBINANT ADENOASSOCIATED VIRUS (AAV) VECTORS CONTAINING B7-1 AND B7-2 GENES PROVIDE POTENT COSTIMULATORY SIGNALS FOR T-CELL PROLIFERATION
Authors: HALLEK M WENDTNER CM MANGOLD E NOLTE A BRAUNFALCO M CHIORINI JA KOTIN RM MAASS G EMMERICH B WINNACKER EL
Citation: M. Hallek et al., HUMAN LYMPHOID TUMOR-CELLS TRANSDUCED WITH RECOMBINANT ADENOASSOCIATED VIRUS (AAV) VECTORS CONTAINING B7-1 AND B7-2 GENES PROVIDE POTENT COSTIMULATORY SIGNALS FOR T-CELL PROLIFERATION, Blood, 86(10), 1995, pp. 3984-3984
ACYCLOVIR TREATMENT
Authors: MAASS G
Citation: G. Maass, ACYCLOVIR TREATMENT, Deutsche Medizinische Wochenschrift, 119(18), 1994, pp. 679-679
QUANTITATIVE DETECTION OF NEUTRALIZING ANTIBODIES AGAINST POLIOVIRUSES AND NON-POLIO ENTEROVIRUSES (NPEV) USING AN AUTOMATED MICRONEUTRALIZATION ASSAY - A SEROEPIDEMIOLOGIC SURVEY
Authors: WEBER B RABENAU H CINATL J MAASS G DOERR HW
Citation: B. Weber et al., QUANTITATIVE DETECTION OF NEUTRALIZING ANTIBODIES AGAINST POLIOVIRUSES AND NON-POLIO ENTEROVIRUSES (NPEV) USING AN AUTOMATED MICRONEUTRALIZATION ASSAY - A SEROEPIDEMIOLOGIC SURVEY, Zentralblatt fur Bakteriologie, 280(4), 1994, pp. 540-549
MECHANISMS LEADING TO IL-2 MEDIATED TUMOR REJECTION IN MURINE MELANOMA
Authors: MAASS G ZATLOUKAL K SCHNEEBERGER A SCHMIDT W BERGER M BUSCHLE M COTTEN M WAGNER E STINGL G BIRNSTIEL ML
Citation: G. Maass et al., MECHANISMS LEADING TO IL-2 MEDIATED TUMOR REJECTION IN MURINE MELANOMA, Journal of cellular biochemistry, 1994, pp. 239-239
Risultati: 1-25 | 26-35